A federal appeals court has restricted access to mifepristone by blocking the mailing of prescriptions for the abortion pill. The ruling effectively requires patients to obtain care through in person clinic visits, affecting telemedicine abortion access, enforcement of state bans such as Louisiana’s, and related miscarriage care, while intersecting with FDA rules governing use of the medication.
Swipe through stories, personalise your feed, and save articles for later — all on the app.
